Drugs & Anaphylaxis

Purpose:

The Drugs & Anaphylaxis Committee monitors, provides recommendations to the Board of Regents and implements programs in the area of allergy and asthma pharmaceuticals and anaphylaxis.

Current projects include:

  • Development of study concerning the use of epi-pens and management of drug reactions

Members:

Chair: Dana V. Wallace, MD (11/08)
Vice Chair: Pakit Vichyanond, MD (11/08)

Terms expire 11/08: Terms expire 11/09: Terms expire 11/10:
Antonio Bunker, MD Oner Ozdemir, MD Phillip Lieberman, MD
Myngoc T. Nguyen, MD Mona Imam, MD Paul J. Dowling, MD
Andrew Hope, MD Peter Kao, MD David A. Khan, MD
Scott P. Cummins, MD (FIT)
Consultant:
Joanne Vitanza, MD (Verus)

 

Committee Bulletin Board